体重指数会影响慢性阻塞性肺病和喘患者的螺旋计指数
Xiaohu Wang1, Hui Gan2, Yimin Wang2
1Department of Respiratory and Critical Care Medicine, People's Hospital of Yangjiang, Yangjiang, China.
Frontiers in physiology
|December 18, 2023
概括
身体质量指数 (BMI) 显著影响COPD和喘患者的精神测量结果. 体重不足和肥胖都会影响疾病的诊断和严重程度,需要在患者管理中加以考虑.
科学领域:
- 肺部医学 肺部医学
- 呼吸系统生理学 呼吸系统生理学
- 临床诊断 临床诊断 临床诊断
背景情况:
- 身体质量指数 (BMI) 是影响精神测量结果的已知因素.
- 在慢性阻塞性肺病 (COPD) 和喘中,BMI对螺旋计的具体影响需要进一步调查.
研究的目的:
- 在被诊断患有COPD或喘的患者中调查不同BMI类别和螺旋计指数之间的关联.
- 确定体重不足,正常体重,超重和肥胖如何影响这些患者群体的呼吸功能测量.
主要方法:
- 对3891名COPD和1208名喘患者的回顾性审查,这些患者接受了带有支气管扩展剂测试的螺旋计 (2017-2021年).
- 患者被分为体重不足 (BMI <18.5公斤/米2),正常体重 (18.524.9公斤/米2),超重 (2529.9公斤/米2) 和肥胖 (≥30公斤/米2).
- 在BMI类别中比较支气管扩展前和后的螺旋体指数 (FEV1,FVC,FEV1/FVC).
主要成果:
- 体重不足的COPD患者与正常体重患者相比,FEV1,FVC和FEV1/FVC值显著降低.
- 超重和肥胖的COPD患者表现出明显更高的FEV1,FVC和FEV1/FVC值.
- 体重不足的喘患者的FEV1,FVC和FEV1/FVC较低,而肥胖的喘患者的FEV1/FVC比率较高.
结论:
- 在COPD和喘患者的BMI类别之间,螺旋计指数存在显著差异.
- 体重不足和肥胖状态都会影响COPD和喘的准确诊断和严重程度评估.
- 临床医生在解释螺旋计结果时应考虑BMI,以改善患者管理和诊断.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Factors Affecting Pulmonary Ventilation
1.4K
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
1.4K
COPD: Management Using Bronchodilators and Corticosteroids
213
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
213
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


